Cecilie Fredvik Torkildsen

7PUBLICATIONS
39CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersPsychosocial aspects of childbirth and perinatal mental health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 10, 2026
Clinical outcomes of genomically guided trametinib monotherapy across cancer types: results from the IMPRESS-Norway trial.

Kathinka Schmidt Slørdahl, Katarina Puco, Ragnhild Sørum Falk

|Jan 23, 2024
[Raising the quality of cancer treatment].

Åslaug Helland, Eli Sihn Samdal Steinskog, Egil Støre Blix

|May 16, 2023
Molecular and phenotypic characteristics influencing the degree of cytoreduction in high-grade serous ovarian carcinomas.

Cecilie Fredvik Torkildsen, Liv Cecilie Vestrheim Thomsen, Ragnar Kvie Sande

|Mar 29, 2023
Primary Treatment Effects for High-Grade Serous Ovarian Carcinoma Evaluated by Changes in Serum Metabolites and Lipoproteins.

Cecilie Fredvik Torkildsen, Marie Austdal, Ann-Charlotte Iversen

|Jul 09, 2022
Humanized Ovarian Cancer Patient-Derived Xenografts for Improved Preclinical Evaluation of Immunotherapies.

Katrin Kleinmanns, Stein-Erik Gullaksen, Geir Bredholt

Pageof 2